Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus-Reference-Cited by-同舟云学术

Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus

Published:2016-01-27 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Gu Hongjing,Xie Zhengde,Li Tieling,Zhang Shaogeng,Lai Chengcai,Zhu Ping,Wang Keyu,Han Lina,Duan Yueqiang,Zhao Zhongpeng,Yang Xiaolan,Xing Li,Zhang Peirui,Wang Zhouhai,Li Ruisheng,Yu Jane J.,Wang Xiliang,Yang Penghui

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep19840.pdf

Reference30 articles.

1. Waghmare, A. et al. Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment and clinical outcomes. Clin Infect Dis 57, 1731–41 (2013).

2. Shirey, K. A. et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4- and IFN-beta-dependent. Mucosal Immunol 3, 291–300 (2010).

3. Hall, C. B. et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 360, 588–98 (2009).

4. Papin, J. F. et al. Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol 304, L530–9 (2013).

5. Liesman, R. M. et al. RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction. J Clin Invest 124, 2219–33 (2014).

Cited by 199 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of an engineered ACE2 protein for its improved biological features and its transduction into MSCs: A novel approach to combat COVID-19 infection;International Journal of Biological Macromolecules;2024-10

2. Organic Dust Exposure Enhances SARS-CoV-2 Entry in a PKCα- and ADAM-17-Dependent Manner;International Journal of Translational Medicine;2024-07-18

3. Substance P – a regulatory peptide with defense and repair functions. Results and perspectives for the fight against COVID-19;Frontiers in Neurology;2024-05-30

4. P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation;Signal Transduction and Targeted Therapy;2023-10-09

5. Altered renin-angiotensin system gene expression in airways of antigen-challenged mice: ACE2 downregulation and unexpected increase in angiotensin 1–7;Respiratory Physiology & Neurobiology;2023-10